Back to Search
Start Over
Association of increasing age with receipt of specialist care and long-term mortality in patients with non-ST elevation myocardial infarction.
- Source :
-
Age and ageing [Age Ageing] 2016 Jan; Vol. 45 (1), pp. 96-103. Date of Electronic Publication: 2015 Nov 24. - Publication Year :
- 2016
-
Abstract
- Background: observational studies suggest that older patients are less likely to receive secondary prevention medicines following acute coronary syndrome (ACS).<br />Objectives: to examine the association of increasing age with receipt of specialist care and influence of specialist care on long-term mortality in patients with non-ST elevation myocardial infarction (NSTEMI).<br />Design: a cohort study.<br />Setting: National ACS registry of England and Wales.<br />Subjects: a total of 85,183 patients admitted with NSTEMI between 2006 and 2010.<br />Methods: logistic regression analyses to assess receipt of secondary prevention medicines (ACE inhibitor, β-blocker, statin, aspirin) by age group; multivariate Cox regression models to examine longitudinal effect of cardiologist care on all-cause mortality by age group.<br />Results: mean age 72.0 years (SD 13.0 years), mean follow-up was 2.13 years. Older patients received less cardiologist care (70.2% of NSTEMI patients ≥85 years compared with 94.7% of patients <65) years and had more co-morbidity. Cardiologists prescribed more secondary prevention in all age groups than generalists, but this was mostly explained away by co-morbidity (receipt of statin crude OR 1.51 (1.27,1.80), fully adjusted OR 1.11 (0.92,1.33) in patients ≥85 years). Receiving cardiologist care compared with generalist care was associated with a decreased risk of death in all even after adjustment for co-morbidity, disease severity and secondary prevention; this benefit reduced incrementally with older age group (adjusted hazard ratio (HR) 0.58 (0.49,0.68) aged <65; 0.87 (0.82,0.92) aged ≥85).<br />Conclusion: older patients with NSTEMI were less likely to see a cardiologist, but reduced treatment by generalists was explained away by co-morbidity. Cardiologist care was associated with lower mortality in all age groups than a generalist, but this survival benefit was less pronounced in older patients.<br /> (© The Author 2015. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Subjects :
- Adrenergic beta-Antagonists therapeutic use
Age Factors
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors therapeutic use
Aspirin therapeutic use
Comorbidity
England
Female
General Practice
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
Logistic Models
Longitudinal Studies
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction diagnosis
Myocardial Infarction prevention & control
Odds Ratio
Proportional Hazards Models
Referral and Consultation
Registries
Risk Factors
Time Factors
Treatment Outcome
Wales
Cardiology
Cardiovascular Agents therapeutic use
Delivery of Health Care
Myocardial Infarction therapy
Secondary Prevention
Specialization
Subjects
Details
- Language :
- English
- ISSN :
- 1468-2834
- Volume :
- 45
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Age and ageing
- Publication Type :
- Academic Journal
- Accession number :
- 26601697
- Full Text :
- https://doi.org/10.1093/ageing/afv162